Form 4 for RXST RxSight, Inc.
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0000899243-21-031822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-05 | 2021-08-03 | RXST | LINK WILLIAM J PHD | Dir, 10% | P - Purchase | $16.00 | +31.2K | 37.1K | +533% | +$500.0K |
| DI | 2021-08-05 | 2021-08-03 | RXST | LINK WILLIAM J PHD | Dir, 10% | C - Cnv Deriv | $0.00 | +2.02M | 2.02M | New | $0 |
| DI | 2021-08-05 | 2021-08-03 | RXST | LINK WILLIAM J PHD | Dir, 10% | C - Cnv Deriv | $0.00 | -2.02M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | P | A | 31,250 | $16.00 | 37,109 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-03 | C | A | 2,016,778 | $0.00 | 2,016,778 | I See footnote | — | — | (F1) All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. (F2) Shares held by RxSight I, LLC. The Reporting Person is a managing member of RxSight I, LLC and may be deemed to share voting and investment power over the securities held by RxSight I, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| 3 | Derivative | Series H Preferred Stock | 2021-08-03 | C | D | 2,016,778 | $0.00 | 0 | I See footnote | — · — to — | 2,016,778 Common Stock | (F1) All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. (F2) Shares held by RxSight I, LLC. The Reporting Person is a managing member of RxSight I, LLC and may be deemed to share voting and investment power over the securities held by RxSight I, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |